Furthermore, combination of perinodular delta radiomics with PD-L1 expression was superior to PD-L1 alone for predicting OS, highlighting the importance of integrating radiomics and biological features into the personalized decision process of NSCLC patients. The gene discussed is CD274; the disease is non-small cell lung carcinoma.